SE7608221L - Forfarande for framstellning av oxaprostaglandiner - Google Patents

Forfarande for framstellning av oxaprostaglandiner

Info

Publication number
SE7608221L
SE7608221L SE7608221A SE7608221A SE7608221L SE 7608221 L SE7608221 L SE 7608221L SE 7608221 A SE7608221 A SE 7608221A SE 7608221 A SE7608221 A SE 7608221A SE 7608221 L SE7608221 L SE 7608221L
Authority
SE
Sweden
Prior art keywords
oxaprostaglandins
procedure
manufacture
Prior art date
Application number
SE7608221A
Other languages
English (en)
Other versions
SE418857B (sv
Inventor
M R Johnson
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer filed Critical Pfizer
Publication of SE7608221L publication Critical patent/SE7608221L/sv
Publication of SE418857B publication Critical patent/SE418857B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7608221A 1972-06-02 1976-07-19 18-oxa och 19-oxa-prostaglandiner till anvendning som antifertilitetsmedel SE418857B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (2)

Publication Number Publication Date
SE7608221L true SE7608221L (sv) 1976-07-19
SE418857B SE418857B (sv) 1981-06-29

Family

ID=26947161

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7307521A SE415756B (sv) 1972-06-02 1973-05-28 Forfarande for framstellning av vissa 18-oxa- och 19-oxa-prostaglandiner
SE7608222A SE7608222L (sv) 1972-06-02 1976-07-19 Forfarande for framstellning av oxaprostaglandiner
SE7608221A SE418857B (sv) 1972-06-02 1976-07-19 18-oxa och 19-oxa-prostaglandiner till anvendning som antifertilitetsmedel
SE7608223A SE7608223L (sv) 1972-06-02 1976-07-19 Forfarande for framstellning av oxaprostaglandiner

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7307521A SE415756B (sv) 1972-06-02 1973-05-28 Forfarande for framstellning av vissa 18-oxa- och 19-oxa-prostaglandiner
SE7608222A SE7608222L (sv) 1972-06-02 1976-07-19 Forfarande for framstellning av oxaprostaglandiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7608223A SE7608223L (sv) 1972-06-02 1976-07-19 Forfarande for framstellning av oxaprostaglandiner

Country Status (19)

Country Link
JP (3) JPS5314062B2 (sv)
AR (2) AR199300A1 (sv)
CA (1) CA1095034A (sv)
CH (3) CH586716A5 (sv)
DD (2) DD124594A5 (sv)
DE (2) DE2344838C3 (sv)
DK (1) DK143498C (sv)
ES (2) ES441003A1 (sv)
FI (1) FI55995C (sv)
GB (3) GB1440603A (sv)
IE (1) IE38568B1 (sv)
IL (2) IL42373A (sv)
IN (1) IN138739B (sv)
LU (1) LU67738A1 (sv)
NL (1) NL162902C (sv)
NO (1) NO145438C (sv)
PH (3) PH11300A (sv)
SE (4) SE415756B (sv)
YU (1) YU36497B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO143741C (no) * 1972-07-13 1981-04-08 Pfizer Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
WO2021040628A1 (en) 2019-08-28 2021-03-04 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
SE415756B (sv) 1980-10-27
FI55995B (fi) 1979-07-31
JPS5314062B2 (sv) 1978-05-15
PH11300A (en) 1977-11-02
IL42373A0 (en) 1973-07-30
IE38568B1 (en) 1978-04-12
AR199300A1 (es) 1974-08-23
CA1095034A (en) 1981-02-03
IL50311A (en) 1977-08-31
GB1440603A (en) 1976-06-23
NO145438B (no) 1981-12-14
SE418857B (sv) 1981-06-29
GB1440602A (en) 1976-06-23
AR203386A1 (es) 1975-09-08
NL162902C (nl) 1980-07-15
DE2344838B2 (de) 1981-04-09
IN138739B (sv) 1976-03-27
CH586716A5 (sv) 1977-04-15
PH11931A (en) 1978-09-13
ES441003A1 (es) 1977-03-16
SE7608222L (sv) 1976-07-19
NL162902B (nl) 1980-02-15
NO145438C (no) 1982-03-24
DE2344838C3 (de) 1982-03-18
PH12035A (en) 1978-10-16
JPS5239629A (en) 1977-03-28
JPS4954349A (sv) 1974-05-27
GB1440601A (en) 1976-06-23
SE7608223L (sv) 1976-07-19
AU5639373A (en) 1974-12-05
YU146973A (en) 1982-02-25
NL7307740A (sv) 1973-12-04
LU67738A1 (sv) 1973-12-10
DE2327813A1 (de) 1973-12-20
IL42373A (en) 1977-08-31
YU36497B (en) 1984-02-29
DK143498C (da) 1982-01-11
DD109859A5 (sv) 1974-11-20
CH589074A5 (sv) 1977-06-30
NO740849L (no) 1973-12-04
CH590224A5 (sv) 1977-07-29
DE2344839B2 (de) 1976-06-24
FI55995C (fi) 1979-11-12
DD124594A5 (sv) 1977-03-02
DK143498B (da) 1981-08-31
DE2344838A1 (de) 1973-12-20
ES441002A1 (es) 1977-03-01
JPS5728706B2 (sv) 1982-06-18
JPS5231054A (en) 1977-03-09
DE2344839A1 (de) 1974-02-28
IE38568L (en) 1973-12-02

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO139689C (no) Fremgangsmaate for fremstilling av lateks
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE392609B (sv) Forfarande for framstellning av metanhaltiga gaser
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
FI55626B (fi) Anordning foer framstaellning av en behaollare
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
NO138364C (no) Anordning til fremstilling av fiberarmerte plastroer
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
FI53935C (fi) Anordning foer framstaellning av en foerpackning av expanderrat plastmaterial
SE395005B (sv) Forfarande for framstellning av 1-arylidenamino-4-(2-oxo-3-fenyl-3-bensofuryl)-piperaziner
SE401506B (sv) Forfarande for framstellning av bifenylyletrar
SE402286B (sv) Forfarande for framstellning av substituerade isokinoliner
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO148849C (no) Analogifremgangsmaate for fremstilling av krystallinsk pivaloyloksymetyl-d-(-)-alfa-aminobenzylpenicillinat
SE382971B (sv) Forfarande for framstellning av ?72238pu?7216o?712
SE403284B (sv) Forfarande for framstellning av uretaner